Gabather AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Public
- Established
- 2014-01-01
- Employees
- 3
- Market Cap
- -
- Website
- http://www.gabather.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study of Ascending Single Oral Dose of GT-002 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Safety and Tolerability
- Interventions
- Drug: Placebo oral capsule
- First Posted Date
- 2019-01-25
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Gabather AB
- Target Recruit Count
- 32
- Registration Number
- NCT03817346
- Locations
- 🇫🇮
CRST Oy, Clinical Research Services Turku, Turku, Finland
News
No news found